RI2A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Rigel Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 10.8 EUR 1.89% Market Closed

Market Cap: €21.9m

R	Rigel Pharmaceuticals Inc F:RI2A	US
	Canopy Growth Corp F:11L	CA
H	Honeywell International Inc BMV:HON	US

Profitability Summary

Rigel Pharmaceuticals Inc's profitability score is 85/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

91%

Strong 3Y Average Gross Margin

92%

Declining Gross Margin

98% > 91%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

-27% > 31%

Exceptional Net Margin

116%

Strong 3Y Average Net Margin

34%

Net Margin is Increasing

-30% > 116%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-38% > 3%

Exceptional ROE

127%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

58%

ROIC is Increasing

-82% > 128%

View All

Hide

Collapse

85 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.